Vitreoretinal lymphoma: Central nervous system lymphoma risk with unilateral or bilateral ocular tumour. A multicentre collaboration.
Lauren A DalvinJose S PulidoCarol L ShieldsAlessandro MarcheseElisabetta MiserocchiShahar FrenkelJacob Pe'erPublished in: Eye (London, England) (2022)
Initial presentation with unilateral VRL and treatment of isolated VRL with systemic chemotherapy were associated with lower risk of developing CNS lymphoma. Further study is required to determine whether select patients with isolated VRL might benefit from systemic chemotherapy in the prevention of CNS lymphoma.